Pharmacy benefits managers (PBMs) have come under growing scrutiny from employers and governments over how they calculate drug costs and the opaque supply chains they are part of. Some PBMs are also owned by large insurance companies, a relationship many argue is inherently conflict-ridden. So can a PBM work effectively to ensure patients are getting access to affordable drugs? Hear from the CEO of an up-and-coming PBM who doesn?t mince his words and calls out the large PBMs for their unfair practices.   Moderator: Arundhati Parmar, Editor-in-Chief, MedCity News Speaker: A.J. Loiacono, CEO, Capital Rx